Myricetin is a member of the group of flavonoids called flavonols.
Myricetin is obtained from various fruit, vegetables, tea, berries and red wine.
Myricetin is characterized by the pysrogallol B-ring, and the more hydroxylated
structure is known to be capable for its increased biological properties
compared with other flavonols. Myricetin is produced by the Myricaceae,
Anacardiaceae, Polygonaceae, Pinaceae and Primulacea families. It is soluble in
organic solvent such as ethanol, DMSO (dimethyl sulfoxide), and dimethyl
formamide (DMF). It is sparingly soluble in aqueous buffers. Myricetin shows its
various pharmacological activities including antioxidant, anti-amyloidogenic,
antibacterial, antiviral, antidiabetic, anticancer, anti-inflammatory,
anti-epileptic and anti-ulcer. This review article focuses on pharmacological
effects of Myricetin on different diseases such as osteoporotic disorder,
anti-inflammatory disorder, alzheimer’s disease, anti-epileptic, cancer,
cardiac disorder, diabetic metabolic disorder, hepatoprotective disorder and
gastro protective disorder.